Literature DB >> 16981292

Musculoskeletal findings and disability in alkaptonuria.

Monique B Perry1, Pim Suwannarat, Gloria P Furst, William A Gahl, Lynn H Gerber.   

Abstract

OBJECTIVE: To describe the musculoskeletal (MSK) findings in patients with alkaptonuria and to show which of these factors are associated with disability in this population.
METHODS: This is a prospective cross-sectional MSK assessment of subjects. Participants included 53 patients with alkaptonuria across the life span, 22 female and 31 male, mean age 43.6 years (10-80 yrs), participating in a natural history study supported by the National Human Genome Research Institute (NHGRI). Assessments included objective measures of the MSK system (range of motion, radiographic assessment of joints and spine, etc.) and questionnaires including the Human Activity Profile (HAP), Health Assessment Questionnaire (HAQ), SF-36 health survey, and the Fatigue Assessment Instrument.
RESULTS: There were 18 patients with kyphosis, 16 with scoliosis, 16 with marked reduction in range of motion of at least one major joint, 15 with joint replacements of major joints, 11 with tendon ruptures. A positive Schober's test was highly correlated with substantial functional loss and associated with disability as measured by the HAP (p < or = 0.0001), HAQ (p < or = 0.0001), and the physical component summary (p < or = 0.0001) of the SF-36 health survey. Severity of lumbar spine involvement had the greatest correlation with disability measures (p < or = 0.0001). All objective and subjective physical measures worsened with age.
CONCLUSION: Disability is common and severe in patients with alkaptonuria and correlates well with physical findings. Disability does not correlate with self-reports of mental competencies. Aging with alkaptonuria is associated with progressive disability.

Entities:  

Mesh:

Year:  2006        PMID: 16981292

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

1.  Alkaptonuria: leading to the treasure in exceptions.

Authors:  Timothy M Cox
Journal:  JIMD Rep       Date:  2011-12-06

2.  Alkaptonuria in a middle-aged female.

Authors:  Aref Hosseinian Amiri; Alireza Rafiei
Journal:  Caspian J Intern Med       Date:  2012

3.  [Acute bilateral shoulder pain as initial presentation of ochronosis: a case report and literature review].

Authors:  N Laktasic-Zerjavic; B Curkovic; D Babic-Naglic; K Potocki; M Prutki; D Soldo-Juresa
Journal:  Z Rheumatol       Date:  2010-07       Impact factor: 1.372

4.  Mutation spectrum of homogentisic acid oxidase (HGD) in alkaptonuria.

Authors:  Thierry Vilboux; Michael Kayser; Wendy Introne; Pim Suwannarat; Isa Bernardini; Roxanne Fischer; Kevin O'Brien; Robert Kleta; Marjan Huizing; William A Gahl
Journal:  Hum Mutat       Date:  2009-12       Impact factor: 4.878

Review 5.  Alkaptonuria.

Authors:  Jemma B Mistry; Marwan Bukhari; Adam M Taylor
Journal:  Rare Dis       Date:  2013-12-18

Review 6.  Ochronotic arthropathy as a paradigm of metabolically induced degenerative joint disease. A case-based review.

Authors:  L Ventura-Ríos; C Hernández-Díaz; L Gutiérrez-Pérez; A Bernal-González; R Pichardo-Bahena; A L Cedeño-Garcidueñas; C Pineda
Journal:  Clin Rheumatol       Date:  2014-03-20       Impact factor: 2.980

Review 7.  A Mimic of Ankylosing Spondylitis, Ochronosis: Case Report and Review of the Literature.

Authors:  Philip Chu; Maria C Cuellar; Sonali J Bracken; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2021-03-05       Impact factor: 4.806

8.  Alkaptonuria, more than just a mere disease.

Authors:  Abdul Qayyum Rana; Usman Saeed; Ismael Abdullah
Journal:  J Neurosci Rural Pract       Date:  2015 Apr-Jun

9.  Alkaptonuria: A case report.

Authors:  Nirupama Damarla; Prathima Linga; Mallika Goyal; Sanjay Reddy Tadisina; G Satyanarayana Reddy; Hymavathi Bommisetti
Journal:  Indian J Ophthalmol       Date:  2017-06       Impact factor: 1.848

Review 10.  Treatment of nongout joint deposition diseases: an update.

Authors:  Tristan Pascart; Pascal Richette; René-Marc Flipo
Journal:  Arthritis       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.